|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-9-12
|
|
pubmed:abstractText |
Patients with multiple myeloma have a high risk of venous thromboembolism (VTE), especially during the induction chemotherapy. The aim of our observational study was to determine the impact of prophylaxis with low molecular weight heparin (LMWH) on the incidence of thromboembolic complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0862-495X
|
|
pubmed:author |
pubmed-author:AdarAA,
pubmed-author:BacovskyJJ,
pubmed-author:BrejchaMM,
pubmed-author:Czech Myeloma Group,
pubmed-author:FenclovaMM,
pubmed-author:FrankovaHH,
pubmed-author:GregoriMM,
pubmed-author:GumulecJJ,
pubmed-author:HajduGG,
pubmed-author:HausdorfPP,
pubmed-author:HeinzovaVV,
pubmed-author:HolikovaMM,
pubmed-author:KesslerPP,
pubmed-author:KrejciMM,
pubmed-author:KubackovaKK,
pubmed-author:LangrovaEE,
pubmed-author:MaisnarVV,
pubmed-author:MeluzinovaII,
pubmed-author:PenkaMM,
pubmed-author:PourLL,
pubmed-author:ScudlaVV,
pubmed-author:StavarovaYY,
pubmed-author:StraubJJ,
pubmed-author:UllrychovaJJ,
pubmed-author:WalterovaLL,
pubmed-author:ZemanovaMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
281-6
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.
|
|
pubmed:affiliation |
Department of Hematology and Transfusion Medicine, Hospital Pelhrimov, Czech Republic pkessler@hospital-pe.cz
|
|
pubmed:publicationType |
Journal Article
|
